ClinicalTrials.Veeva

Menu

Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)

I

Insel Gruppe AG, University Hospital Bern

Status

Enrolling

Conditions

Coronary Artery Disease
Coronary; Ischemic
Coronary Arteriosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT04827316
2021-00058

Details and patient eligibility

About

In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.

Full description

In this study the investigators retrospectively and prospectively collect information from enrolled subjects through a period of a total of 10 years to evaluate multidimensional associations between phenotypic manifestations of cardiovascular disease via CCTA and cardiac and non-cardiac imaging, serum biomarkers, demographic and clinical information, clinical presentation (cross-sectional), therapy changes (time-varying) and their ability to predict mortality and MACE (major adverse cardiac event ) (longitudinal) in patients clinically indicated for CCTA.

The aim is to establish a comprehensive cross-sectional, time-varying and longitudinal data collection for individuals undergoing clinically-indicated CCTA to date in order to apply novel multiparametric approaches to determine cardiovascular significance to clinically-important patient-centered events. For data collection this registry will follow a standard CRF (case report form) structure, so to enable the merging of this data-set with other international registries, which might contribute in overcoming some gaps of knowledge from previous CCTA studies.

Enrollment

4,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult individual >18 years
  • Undergoing clinically indicated CCTA
  • Signed informed consent or waiver

Exclusion criteria

  • None

Trial design

4,200 participants in 1 patient group

Patients undergoing clinically indicated CCTA
Description:
Patients undergoing clinically indicated CCTA

Trial contacts and locations

1

Loading...

Central trial contact

Christoph Gräni, MD, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems